Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$2.29
-0.0600 (-2.55%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $1.66 $2.47 Friday, 10th May 2024 PTN stock ended at $2.29. This is 2.55% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 11.76% from a day low at $2.21 to a day high of $2.47.
90 days $1.47 $4.65
52 weeks $1.43 $5.65

Historical Palatin Technologies Inc prices

Date Open High Low Close Volume
Nov 25, 2016 $0.600 $0.700 $0.585 $0.694 3 666 200
Nov 23, 2016 $0.580 $0.590 $0.560 $0.585 1 608 400
Nov 22, 2016 $0.543 $0.595 $0.527 $0.580 3 660 800
Nov 21, 2016 $0.530 $0.545 $0.512 $0.530 1 533 400
Nov 18, 2016 $0.520 $0.536 $0.506 $0.520 1 516 100
Nov 17, 2016 $0.500 $0.550 $0.490 $0.520 3 173 100
Nov 16, 2016 $0.510 $0.534 $0.502 $0.520 1 703 900
Nov 15, 2016 $0.567 $0.579 $0.503 $0.513 3 869 500
Nov 14, 2016 $0.550 $0.570 $0.531 $0.550 1 659 100
Nov 11, 2016 $0.510 $0.530 $0.485 $0.530 1 799 200
Nov 10, 2016 $0.520 $0.526 $0.496 $0.500 1 619 900
Nov 09, 2016 $0.510 $0.530 $0.505 $0.510 1 629 900
Nov 08, 2016 $0.510 $0.530 $0.490 $0.525 2 209 400
Nov 07, 2016 $0.516 $0.538 $0.500 $0.510 1 788 300
Nov 04, 2016 $0.520 $0.537 $0.490 $0.505 2 433 800
Nov 03, 2016 $0.599 $0.600 $0.512 $0.522 4 738 800
Nov 02, 2016 $0.750 $0.750 $0.503 $0.570 30 685 200
Nov 01, 2016 $0.520 $0.520 $0.480 $0.484 953 300
Oct 31, 2016 $0.515 $0.520 $0.480 $0.520 866 100
Oct 28, 2016 $0.510 $0.520 $0.500 $0.505 623 300
Oct 27, 2016 $0.520 $0.520 $0.503 $0.516 678 300
Oct 26, 2016 $0.520 $0.540 $0.500 $0.516 979 900
Oct 25, 2016 $0.540 $0.543 $0.453 $0.510 2 183 100
Oct 24, 2016 $0.550 $0.558 $0.534 $0.540 867 700
Oct 21, 2016 $0.540 $0.544 $0.521 $0.543 944 500
Click to get the best stock tips daily for free!

About Palatin Technologies Inc

Palatin Technologies Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatmen... PTN Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT